Development and characterization of polymer lipid hybrid nanoparticles for oral delivery of LMWH

Artif Cells Nanomed Biotechnol. 2017 Dec;45(8):1631-1639. doi: 10.1080/21691401.2016.1276920. Epub 2017 Jan 10.

Abstract

The present study aimed to develop an improved oral delivery system for low-molecular-weight heparin (LMWH), novel polymer lipid hybrid nanoparticles were developed. LMWH loaded chitosan polymer lipid hybrid nanoparticles (LMWH-CS-PLNs) were developed using double emulsification and solvent evaporation method. The performance of developed formulations was evaluated by using in vitro and in vivo behavior, such as drug release studies, in vitro permeation study, in vivo venous thrombolytic study, in vitro uptake studies by using intestinal epithelium resembling Caco-2 cell lines. The new CS-PLNs might provide an effective strategy for oral delivery of LMWH with improved encapsulation efficiency as compared to CS-NPs and SA-LNPs.

Keywords: Lipid nanoparticles; chitosan nanoparticles; hydrophilic; low molecular weight heparin; polymer lipid hybrid nanoparticles.

MeSH terms

  • Administration, Oral
  • Amines / chemistry*
  • Biological Transport
  • Caco-2 Cells
  • Chitosan / chemistry*
  • Drug Carriers / chemistry*
  • Drug Carriers / metabolism
  • Heparin, Low-Molecular-Weight / administration & dosage*
  • Heparin, Low-Molecular-Weight / chemistry*
  • Heparin, Low-Molecular-Weight / therapeutic use
  • Humans
  • Nanoparticles / chemistry*
  • Permeability
  • Venous Thrombosis / drug therapy

Substances

  • Amines
  • Drug Carriers
  • Heparin, Low-Molecular-Weight
  • Chitosan
  • stearylamine